| Date Filed | Type | Description |
| 05/25/2023 |
4
| Schwartz Jeffrey Lawrence (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 4,648 shares
@ $0
Granted 13,774 options to buy
@ $32.27, valued at
$444.5k
|
|
| 05/05/2023 |
4
| Schwartz Jeffrey Lawrence (10% Owner) has filed a Form 4 on RAPID MICRO BIOSYSTEMS, INC.|
Txns:
| Granted 25,000 options to buy
@ $0.8705, valued at
$21.8k
|
|
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Schwartz Jeffrey Lawrence (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 4,818 shares
@ $0
Granted 15,318 options to buy
@ $35.42, valued at
$542.6k
|
|
| 08/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2021 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on RAPID MICRO BIOSYSTEMS, INC.|
Txns:
| Converted 6,999,998 shares
@ $0
Converted 1,334,562 shares
@ $0
Bought 100,000 shares
@ $20, valued at
$2M
Converted 35,000,001 options to buy
@ $0
Converted 6,672,819 options to buy
@ $0 |
|
| 07/16/2021 |
4
| Schwartz Jeffrey Lawrence (10% Owner) has filed a Form 4 on RAPID MICRO BIOSYSTEMS, INC.|
Txns:
| Granted 25,000 options to buy
@ $20, valued at
$500k
|
|
| 07/14/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/27/2020 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Bought 3,333,333 shares
@ $3, valued at
$10M
|
|
| 10/26/2020 |
4
| Schwartz Jeffrey Lawrence (CEO) has filed a Form 4 on BCLS Acquisition Corp.|
Txns:
| Granted 487,500 shares
@ $10, valued at
$4.9M
|
|
| 10/21/2020 |
3
| Schwartz Jeffrey Lawrence (CEO) has filed a Form 3 on BCLS Acquisition Corp. |
| 07/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/23/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/22/2020 |
4
| Schwartz Jeffrey Lawrence (10% Owner) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 7,464 options to buy
@ $38.03, valued at
$283.9k
|
|
| 02/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/30/2020 |
3
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 3 on Arcutis Biotherapeutics, Inc. |
| 01/16/2020 |
3
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 3 on Aptinyx Inc. |
| 11/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2019 |
4
| Schwartz Jeffrey Lawrence (10% Owner) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 29,983 options to buy
@ $18, valued at
$539.7k
Granted 40,000,000 convertible preferred
@ $0
Granted 6,931,142 convertible preferred
@ $0 |
|
| 09/12/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/31/2019 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Sold 1,600,000 shares
@ $12.5, valued at
$20M
|
|
| 07/26/2018 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Converted 2,338,968 shares
@ $0
Bought 500,000 shares
@ $15, valued at
$7.5M
Converted 235,146 convertible preferred
@ $0 |
|
| 07/19/2018 |
3
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 3 on Replimune Group, Inc. |
| 12/19/2017 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on MARINUS PHARMACEUTICALS INC|
Txns:
| Sold 719,665 shares
@ $8.0179, valued at
$5.8M
Sold 102,882 shares
@ $8.636, valued at
$888.5k
Sold 300,000 shares
@ $7.5048, valued at
$2.3M
Sold 94,771 shares
@ $7.6209, valued at
$722.2k
Sold 55,229 shares
@ $7.1055, valued at
$392.4k
|
|
| 12/19/2017 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Bought 285,000 shares
@ $7, valued at
$2M
Exercised 8,454,388 shares
@ $0
Granted 190,849 shares
@ $0
Exercised 250,000 options to buy
@ $3.19, valued at
$797.5k
|
|
| 04/13/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |